Sanara Medtech

SMTI · NASDAQ

$33.14+$0.00 (+0.00%)TodayMarket closed ·
Prev close $33.14

About SMTI

Sanara MedTech, Inc. engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. The company is headquartered in Fort Worth, Texas and currently employs 108 full-time employees. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. The company markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.

Employees
108
Headquarters
Fort Worth, Texas
Listed
Apr 7, 1994
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

Sanara Medtech executives
NameTitleSince
Ronald Nixon—2019
Seth Yon—2025
Elizabeth Taylor——
Suresh Muppalla——
Jacob Waldrop——
Ann Salamone——
Robert DeSutter——
Roszell Mack——
Eric Major——
Keith Myers——
Sara Ortwein——
Eric Tanzberger——

Revenue by product and region

Fiscal year ended Dec 31, 2025: $103.12M total revenue

By product

  • Soft Tissue Repair Products [Member]$91.35M88.6%
  • Bone Fusion Products [Member]$11.77M11.4%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Sanara Medtech suppliers and customers
CompanyRelationshipCorrelation
Cook Group IncorporatedSupplier—
Rochal Industries LLCSupplier and customer—

Similar companies

Companies in the same industry as Sanara Medtech

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.